Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7288254
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
granted patentUS 7282205
Anti-hepatitis A virus antibodies
granted patentUS 7282206
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
granted patentUS 7279294
Tumor markers in ovarian cancer
granted patentUS 7279320
Curlicue vaccine strain of Bacillus anthracis
granted patentUS 7279163
Water-in-oil emulsion vaccines
granted patentUS 7276227
Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
granted patentUS 7271150
Modified growth hormone
granted patentUS 7268118
Thymosin Ξ²4 compositions
granted patentUS 7267941
Cyanovirin variant-polymer conjugates
granted patentUS 7267823
Ebola peptides and immunogenic compositions containing same
granted patentUS 7265215
DNA or RNA encoding a recombinant dengue envelope protein
granted patentUS 7264947
Activity dependent neurotrophic factor III (ADNF III)
granted patentUS 7262027
Polypeptide and DNA immunization against Coccidioides spp. infections
granted patentUS 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted patentUS 7261896
Methods for preventing strokes by inducing tolerance to e-selectin
granted patentUS 7259167
Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds havi
granted patentUS 7259142
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target
granted patentUS 7258863
Heterologous protection induced by immunization with invaplex vaccine
granted patentUS 7258859
Method for the treatment of multiple sclerosis
granted patentUS 7256260
Human p53 mutations and a genetic system in yeast for functional identification of human p
granted patentUS 7256281
Recombinant P. falciparum merozoite protein-142 vaccine
granted patentUS 7256256
CDK4 binding peptide
granted patentUS 7256004
Variants of humanized anti-carcinoma monoclonal antibody CC49
granted